By FMTeam India’s chemical industry supplies essential materials to pharmaceuticals, agriculture, automobiles, electronics, textiles, construction and consumer-product companies. The sector includes bulk chemicals, fluorochemicals, agrochemical intermediates, performance materials and high-value specialty chemicals.
Indian manufacturers may benefit as global customers diversify their supply chains and seek reliable production partners outside China. However, the chemical industry remains cyclical. Raw-material prices, global demand, environmental rules, plant utilisation and customer inventory levels can significantly affect earnings.
The following companies were selected based on their FY26 financial performance, manufacturing capabilities, product portfolio, balance-sheet strength and future expansion plans.
| Company | Chemical Business Profile | FY26 Revenue | Main Growth Catalyst | Investment Profile |
| SRF | Specialty chemicals and fluorochemicals | ₹15,786.51 crore | New-generation refrigerants and active ingredients | Diversified industry leader |
| PI Industries | Custom synthesis and life sciences | ₹6,713.7 crore | Pharma CRDMO and new molecules | Cash-rich specialty play |
| Deepak Nitrite | Chemical intermediates and phenolics | ₹7,947 crore | Integrated polycarbonate project | Large import-substitution opportunity |
| Navin Fluorine | Fluorochemicals and pharmaceutical CDMO | ₹3,313.9 crore | Specialty and CDMO capacity expansion | High-growth fluorine play |
| Aarti Industries | Benzene-based specialty chemicals | ₹9,018 crore | Long-term global supply contracts | Recovery and expansion opportunity |
1. SRF
Best for: Diversified exposure to specialty chemicals and fluorochemicals
- FY26 consolidated revenue: ₹15,786.51 crore
- Operational EBIT: ₹3,008 crore
- FY26 profit after tax: ₹1,835.18 crore
- Revenue growth: 7%
- PAT growth: 47%
SRF is one of India’s largest diversified chemical companies. Its chemical operations cover specialty intermediates, refrigerants, fluoropolymers and industrial chemicals. It also operates performance-film and technical-textile businesses.
The company’s FY26 operational EBIT increased by 29%, while profit after tax rose by 47%. The chemicals business benefited from stronger refrigerant volumes, better product realisations and steady demand for industrial chemicals and fluoropolymers.
Key Growth Catalyst: New-Generation Refrigerants
SRF has expanded its proposed investment in a new-generation refrigerants project to approximately ₹2,300 crore. The revised project includes a 20,000-tonne annual HFO facility, a 30,000-tonne hydrofluoric acid plant and additional value-added derivatives.
HFO refrigerants have lower global-warming potential than several traditional refrigerants. Demand may increase as environmental regulations encourage industries to adopt cleaner cooling technologies.
SRF is also developing active ingredients and new specialty-chemical products for global customers.
Advantage: Its diversified business model, technical knowledge and large manufacturing base reduce dependence on one chemical product.
Limitation: The specialty-chemical business faces pricing pressure, changing customer schedules and long project-qualification periods.
2. PI Industries
Best for: Custom synthesis, agrochemical innovation and balance-sheet strength
- FY26 consolidated revenue: ₹6,713.7 crore
- FY26 EBITDA: ₹1,705.3 crore
- EBITDA margin: Approximately 25%
- FY26 profit after tax: ₹1,320.8 crore
- Cash and investments: Approximately ₹3,426.5 crore
PI Industries is a research-led life sciences and specialty-chemical company. It manufactures complex molecules for global agricultural innovators and also sells branded crop-protection products in India.
FY26 revenue declined by approximately 16% because of weak global agrochemical demand, customer delivery schedules and high inventory across the supply chain. Despite this decline, PI maintained an EBITDA margin of about 25% and remained debt-free with a large cash balance.
Key Growth Catalyst: Pharma CRDMO
PI is expanding beyond agrochemicals into pharmaceutical contract research, development and manufacturing. Its pharmaceutical revenue grew by approximately 40% during FY26.
The company is also diversifying its custom-synthesis pipeline into electronic chemicals, specialty chemicals, biological products and other non-agricultural applications. Non-agrochemical projects now account for more than 40% of new enquiries.
Advantage: Strong cash reserves, research capabilities and long customer relationships provide financial flexibility during a chemical downcycle.
Limitation: Export revenue remains concentrated among a limited number of international agrochemical customers.
3. Deepak Nitrite
Best for: Integrated intermediates and domestic import substitution
- FY26 total revenue: ₹7,947 crore
- FY26 EBITDA: ₹1,041 crore
- Manufacturing locations: Six major locations
- Export presence: More than 50 countries
- Major planned investment: Approximately ₹5,000 crore in polycarbonate
Deepak Nitrite manufactures chemical intermediates used in pharmaceuticals, agrochemicals, dyes, plastics, textiles, paper and personal-care products. Its subsidiary, Deepak Phenolics, is a major domestic producer of phenol, acetone and isopropyl alcohol.
FY26 performance was affected by weak chemical prices and subdued international demand. However, the company maintained high asset utilisation in its phenolics operations and commissioned new nitration, hydrogenation and nitric acid facilities.
Key Growth Catalyst: Polycarbonate Manufacturing
Deepak Chem Tech is investing around ₹5,000 crore to develop a 165,000-tonne annual polycarbonate resin plant at Dahej. The plant is expected to be commissioned by the fourth quarter of FY28.
Polycarbonate is used in automobiles, electric vehicles, electronics, construction materials, medical equipment, aviation and other advanced applications. India currently depends significantly on imports for this material.
The company is also developing downstream products such as MIBK and MIBC, which may deepen integration with its existing phenol and acetone operations.
Advantage: Backward and forward integration may improve cost control while creating opportunities in imported chemical categories.
Limitation: Large projects involve commissioning, funding and market-cycle risks. Current earnings remain exposed to phenol and acetone prices.
4. Navin Fluorine International
Best for: Fast-growing fluorochemicals and pharmaceutical CDMO exposure
- FY26 consolidated revenue: ₹3,313.9 crore
- FY26 operating EBITDA: ₹1,081.7 crore
- Operating EBITDA margin:6%
- FY26 profit after tax: Approximately ₹663.6 crore
- Revenue growth: 41%
Navin Fluorine manufactures refrigerants, inorganic fluorides, specialty fluorochemicals and pharmaceutical intermediates. It also provides contract development and manufacturing services to global pharmaceutical companies.
FY26 was a strong year for the company. Revenue increased by 41%, while operating EBITDA more than doubled. Growth was broad-based across high-performance products, specialty chemicals and CDMO operations.
Key Growth Catalyst: Specialty Capacity Expansion
Navin Fluorine is investing in new R32 refrigerant capacity, advanced materials, specialty products and multi-purpose manufacturing facilities. It is also executing a dedicated project for global chemical company Chemours.
Its CDMO business is expanding through additional pharmaceutical capacity and new customer projects. Commercial supplies have begun from its newer cGMP facility after customer validation.
Advantage: Strong FY26 margins, technical expertise and exposure to multiple high-value fluorine applications.
Limitation: The stock may carry high valuation expectations. Any delay in project ramp-up or customer approvals could affect growth.
5. Aarti Industries
Best for: Recovery potential supported by long-term global contracts
- FY26 revenue: ₹9,018 crore
- FY26 EBITDA: ₹1,172 crore
- FY26 profit after tax: ₹419 crore
- Revenue growth: 12%
- PAT growth: 27%
Aarti Industries is a major manufacturer of benzene-based specialty chemicals. Its products are used in agrochemicals, pharmaceuticals, polymers, dyes, pigments, fuel additives and personal-care products.
FY26 revenue increased by 12%, while EBITDA grew by 15%. The company benefited from higher volumes, stronger exports and cost-optimisation measures despite volatile raw-material prices and supply-chain disruption.
Key Growth Catalyst: Strategic Global Contracts
Aarti signed a $150 million multi-year agreement to supply a critical agrochemical intermediate to a global customer through March 2030. The contract requires limited additional capital expenditure.
It also entered a backward-integration arrangement with another international chemical company. Aarti plans to invest approximately ₹200 crore to ₹250 crore to serve the remaining 15-year contract period.
These agreements may provide better revenue visibility while improving the utilisation of existing and recently commissioned plants.
Advantage: A broad product portfolio and long-term customer contracts can support recovery as global chemical demand improves.
Limitation: The company carries meaningful debt and capital expenditure. Benzene and aniline price volatility may also affect margins.
Key Risks for Investors
Chemical stocks face several important risks:
- Global demand cycles: Weakness in pharmaceuticals, agriculture, automobiles or construction can reduce chemical demand.
- Raw-material volatility: Prices of benzene, crude-oil derivatives, fluorspar and other inputs may change rapidly.
- Chinese competition: Excess production from China can reduce international chemical prices.
- Environmental regulations: Chemical plants require strict pollution, waste-management and safety compliance.
- Customer concentration: Custom-synthesis companies may depend on a few major global clients.
- Project execution: New facilities can face construction delays, customer-approval issues and slow capacity utilisation.
- High valuations: Specialty-chemical stocks may correct sharply when earnings growth fails to meet expectations.
SRF offers the most diversified chemical exposure, while PI Industries provides strong research capabilities and financial flexibility. Deepak Nitrite represents a large import-substitution opportunity. Navin Fluorine offers faster fluorochemical and CDMO growth, and Aarti Industries provides recovery potential backed by long-term contracts.
Investors should compare valuations, debt, operating cash flow, capacity utilisation and customer concentration before purchasing any chemical stock. This article is for informational purposes and should not be treated as investment advice.